Photo shows vials of COVIRAN Barekat, an Iranian vaccine candidate being developed to tackle the coronavirus.
Iranian health ministry officials say a home-made vaccine meant to tackle the COVID-19, the disease caused by the coronavirus pandemic, has proven safe after a first trial on volunteers showed they had no serious adverse reaction to the jab.
Ehsan Shamsi Koushki, who serves as secretary of the committee on medical ethics in the Iranian health ministry, said on Saturday that his department had allowed COVIRAN Barekat, the Iranian vaccine candidate that started its official human trial last month, be tested on seven more individuals in a third round of the probe.
“Those seven individuals who were injected with the first dose of the vaccine had no serious side effects,” said Shamsi Koushki, adding that the new group of volunteers will get the shot in their arms within the next 28 days.
The announcement came as Iran scrambles to launch a nationwide vaccination program to tackle one of the largest outbreaks of COVID-19 in the Middle East region.
Health ministry officials said on Saturday that they will start the third and final trial phase for a Cuban-Iranian vaccine in the next three months.
Iran in second trial phase for bionational COVID-19 vaccine: Geneticist A bionational COVID-19 vaccine involving Iran is in its second trial phase, according to a geneticist.
Cuban officials announced on Friday that they had signed an agreement with Iranian counterparts to transfer the technology for one of their most advanced coronavirus vaccine candidates.
Cuba’s Finlay Vaccine Institute will collaborate with Iran’s Pasteur Institute to run human trials for the vaccine in Iran.
To further expand its vaccination program, Iran has placed orders to purchase nearly 17 million doses of a vaccine being developed by the World Health Organization (WHO).
The purchase had faced payment issues over US sanctions on Iran although officials said earlier this weeks that they had found a way round the sanctions to transfer the payment to the WHO agent in Switzerland.
Press TV’s website can also be accessed at the following alternate addresses:
- Experts call for vaccine transparency [https://dailyasianage.com/news/252000/experts-call-for-vaccine-transparency]
- India to start vaccination drive from Jan 16 [https://dailyasianage.com/news/252008/india-to-start-vaccination-drive-from-jan-16]
- China’s coronavirus rollout plan revealed as authorities aim to vaccinate 50 million before Lunar New Year [https://www.abc.net.au/news/2021-01-10/china-coronavirus-vaccine-approved-covid-lunar-new-year-travel/13037102]
- Peru’s FA Min: There are advanced negotiations with other laboratories for more vaccines [https://andina.pe/ingles/noticia-perus-fa-min-there-are-advanced-negotiations-with-other-laboratories-for-more-vaccines-829173.aspx]
- Coronavirus: Death toll in UK surpasses 80,000 as cases top 3 million [https://www.euronews.com/2021/01/09/coronavirus-death-toll-in-uk-surpasses-80-000-as-cases-top-3-million]
- The Latest: Israeli PM gets second dose of COVID-19 shot [https://www.mercurynews.com/2021/01/09/the-latest-israeli-pm-gets-second-dose-of-covid-19-shot/]
- Telangana reports to Centre over hurdles in vaccine dry run [https://www.thehansindia.com/telangana/telangana-reports-to-centre-over-hurdles-in-vaccine-dry-run-666173]
- Nearly 15,000 people vaccinated in Oman [https://www.omanobserver.om/nearly-15000-people-vaccinated-in-oman/]
- Around 15,000 people vaccinated in Sultanate [https://www.omanobserver.om/around-15000-people-vaccinated-in-sultanate/]
- A Shot In The Arm: Covid-19 vaccination drive to start in India on Jan 16 [https://www.thehansindia.com/news/national/a-shot-in-the-arm-covid-19-vaccination-drive-to-start-in-india-on-jan-16-666182]
- 1.75 lakh health workers enrolled for vaccine in Bengaluru [https://www.thehansindia.com/news/cities/bengaluru/175-lakh-health-workers-enrolled-for-vaccine-in-bengaluru-666181]